在(zai)2024中(zhong)(zhong)國(guo)(guo)創(chuang)新器械(xie)與(yu)智能制造榜(bang)TOP100、中(zhong)(zhong)國(guo)(guo)創(chuang)新醫藥與(yu)生物制品榜(bang)TOP100、中(zhong)(zhong)國(guo)(guo)醫療(liao)與(yu)健(jian)康創(chuang)新服務榜(bang)TOP100、中(zhong)(zhong)國(guo)(guo)醫療(liao)健(jian)康產業(ye)鏈服務榜(bang)TOP100四張主榜(bang)單中(zhong)(zhong),共計(ji)有(you)(you)400家企(qi)業(ye)上榜(bang),總估(gu)值(zhi)(zhi)約1.26萬億(yi)元,總平均估(gu)值(zhi)(zhi)同(tong)比回(hui)升約2.74%。其中(zhong)(zhong),有(you)(you)86.75%的上榜(bang)企(qi)業(ye)估(gu)值(zhi)(zhi)集中(zhong)(zhong)于10-60億(yi)元區間,構成大健(jian)康產業(ye)非(fei)上市公司主要群(qun)體;12家企(qi)業(ye)估(gu)值(zhi)(zhi)突破百億(yi);2家企(qi)業(ye)估(gu)值(zhi)(zhi)在(zai)200億(yi)元以(yi)上;估(gu)值(zhi)(zhi)排名TOP10企(qi)業(ye)估(gu)值(zhi)(zhi)均值(zhi)(zhi)達145.2億(yi)元。
地區(qu)(qu)分布上,長三角經濟區(qu)(qu)、粵(yue)港澳經濟區(qu)(qu)仍(reng)是大健(jian)(jian)康(kang)企(qi)業(ye)的成(cheng)長沃土;深圳、杭(hang)州為(wei)(wei)大健(jian)(jian)康(kang)企(qi)業(ye)駐地第(di)二梯隊;廣州、蘇州為(wei)(wei)大健(jian)(jian)康(kang)企(qi)業(ye)駐地第(di)三梯隊;以成(cheng)都市(shi)為(wei)(wei)核心的西部(bu)經濟圈大健(jian)(jian)康(kang)產業(ye)正在(zai)快速(su)崛起,成(cheng)為(wei)(wei)醫療(liao)健(jian)(jian)康(kang)企(qi)業(ye)西部(bu)聚集高地。
因文章篇幅有限,以上僅展(zhan)示(shi)2024未來醫療100強的主榜系列榜單(dan),更(geng)多榜單(dan)請以動脈網官方公布為準(zhun)。